PerkinElmer predicts 12% growth in Q2

By The Science Advisory Board staff writers

July 13, 2020 -- PerkinElmer has announced an updated outlook for the second quarter of 2020, predicting 12% revenue growth.

For the quarter (end-July 5), the company said it anticipates roughly 12% growth in reported and organic revenue due to better-than-expected demand for COVID-19-related products. Products that aid with COVID-19 testing contributed approximately $190 million in revenue for the quarter, the company noted.

PerkinElmer announced it will release its full second-quarter results after market close on July 28.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.